Piroxicam Capsules 20mg for Pain Relief and Inflammation

• Customization: Available
• Application: Internal Medicine
• Usage Mode: For oral administration
• Model NO.: AMC11010-01
• State: Solid
• Shape: Capsules
• Type: Biological Products
• Pharmaceutical Technology: Chemical Synthesis
• Packing: 20mg, 10*10/Box, 200boxes/CTN
• CTN Size: 57*29.5*39cm
• OEM/ODM: Support
• Shelf Life: 3 Years
• Transport Package: 10*10/Box
• Specification: 20mg
• Trademark: Medipharm or OEM
• Origin: China
• HS Code: 3004909099
• Production Capacity: 100000ctns/Month

Product Description

Piroxicam Capsule

Name	Piroxicam Capsule
Specification	20mg, 10*10/box, 200boxes/ctn
Shelf Life	3 years
Brand	Medipharm or OEM
Origin	China

Indications:
Symptomatic treatment for relieving pain and swelling of various arthritis and soft tissue lesions.

Contreindication:
This product is not recommended for patients with allergy, peptic ulcer and chronic stomach disease.

Side effects:
1.Gastrointestinal adverse reactions such as nausea, stomach pain, reduction and dyspepsia were the most common, and 3.5% of them required withdrawal. When the dosage is greater than 20mg a day, the incidence of gastric ulcer is significantly increased, and some are combined with bleeding and even perforation.
2. The incidence of neutropenia, eosinophilia, increased blood urea nitrogen, dizziness, vertigo, tinnitus, headache, general weakness, edema, rash or pruritus is 1% to 3%.
3. Incidence of liver dysfunction, thrombocytopenia, hyperhidrosis, skin ecchymosis, peeling, erythema pleomorpha, toxic epithelial necrosis, bullous erythema polyforme (Stevens-Johnson syndrome), skin hypersensitivity to light, blurred vision, eye redness, hypertension, hematuria, hypoglycemia, mental depression, insomnia and mental tension. 

Usage & Dosage:
Common oral dose for adults: 20mg once a day, or 1 l0mg twice a day. Take it after meals.

Storage instructions:
Store below 25ºC. Protect from moisture. Keep out of reach of children.

--------------------------------------------------------------------------------------------------